Related references
Note: Only part of the references are listed.Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
Izildinha Maesta et al.
GYNECOLOGIC ONCOLOGY (2020)
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial
Benoit You et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
Fieke E. M. Froeling et al.
BRITISH JOURNAL OF CANCER (2019)
Can carboplatin or etoposide replace actinomycin-D for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Paulo Alexandre Ribeiro Mora et al.
GYNECOLOGIC ONCOLOGY (2019)
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database
M. M. Frijstein et al.
GYNECOLOGIC ONCOLOGY (2019)
Update on the diagnosis and management of gestational trophoblastic disease
Hextan Y. S. Ngan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia
Ehsan Ghorani et al.
LANCET (2017)
Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia
M. C. Winter et al.
GYNECOLOGIC ONCOLOGY (2016)
Optimal management of low-risk gestational trophoblastic neoplasia
Donald P. Goldstein et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Effects of Single-Agent and Combination Chemotherapy for Gestational Trophoblastic Tumors on Risks of Second Malignancy and Early Menopause
Philip Savage et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. J. Seckl et al.
ANNALS OF ONCOLOGY (2013)
Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia
Izildinha Maesta et al.
GYNECOLOGIC ONCOLOGY (2013)
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009
A. Sita-Lumsden et al.
BRITISH JOURNAL OF CANCER (2012)
Gestational trophoblastic disease
Michael J. Seckl et al.
LANCET (2010)
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
Peter Schmid et al.
LANCET (2009)
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
J. Wang et al.
ANNALS OF ONCOLOGY (2008)
Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
IA McNeish et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment
EI Kohorn
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
Share Paper
